News       Events               CHITIN

 

Director NI Clinical Trials Unit

HSC R&D Division is pleased to announce that in September 2016, Prof Mike Clarke will be the new acting Director of the NICTU.

Prof Clarke has 25 years experience of the conduct and oversight of randomised trials, systematic reviews and other types of prospective research. His work on systematic reviews includes the central collection of individual participant data from hundreds of randomised trials of treatments for women with breast cancer, leading to internationally-renowned reports that influence the care of women worldwide. This research, his other systematic reviews, his role in assessing reports for the Cochrane Central Register of Controlled Trials and his many years of teaching about randomised trials and systematic reviews have provided him with unique insights into the conduct of a vast number of randomised trials. He is building on this experience when designing and conducting research into the methods of evaluations of health and social care. He has been actively involved in the design, conduct, monitoring and reporting of several randomised trials that have recruited more than 1000 participants, in breast cancer, maternity care, poisoning and sub-arachnoid haemorrhage. Prof Mike Clarke Full Bio (QUB website)

Prof Clarke's role as Director of the All Ireland Hub for Trials Methodology Research, has meant that he has been involved with the NICTU since its launch in 2013. He is the current chair of the NICTU Advisory Group and has worked closely with the outgoing NICTU Director, Prof Danny McAuley and with the current NICTU Manager Ms Lynn Murphy.

Under Prof McAuley's leadership the NICTU has established itself as a highly successful UKCRC registered unit with a portfolio that continues to expand and cover a broad spectrum of disease areas, which range from feasibility to late phase studies of investigational medicinal products (IMP) or in the area of public health research.

Mike will be taking on the acting Directorship of the NICTU at an exciting time and will play a key role in ensuring that the NICTU continues to provide the infrastructure and capacity to deliver high quality clinical research in Northern Ireland.

To go to the NICTU website click here >